SCHEMBL3978000

SCHEMBL3978000

C=C(Cc1oc2ccccc2c1C)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ AHR P35869 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ SLC22A12 Q96S37 1/20 0.39
▸ EYA3 Q99504 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ADAMTS4 O75173 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4778437 0.91 CAPN1 (0.38) KCNH2KDM4EAHRNPC1RAB9A
SCHEMBL11365473 0.84 KCNH2 (0.47) KCNH2KDM4EAHRNPC1RAB9A
SCHEMBL7030133 0.80 KCNH2 (0.48) KCNH2KDM4ENPC1RAB9ACYP2C9
SCHEMBL29958593 0.79 ATM (0.43) AHRRAB9AL3MBTL1ALDH1A1HPGD
SCHEMBL4742417 0.76 KDM4E (0.42) KCNH2KDM4ENPC1RAB9ACYP2C9
SCHEMBL353910 0.73 KCNH2 (0.58) KCNH2KDM4EAHRNPC1RAB9A
SCHEMBL5383786 0.72 KDM4E (0.42) KCNH2KDM4EAHRNPC1RAB9A
SCHEMBL2256874 0.72 KDM4E (0.46) KCNH2KDM4ENPC1RAB9ACYP2C9
SCHEMBL4778585 0.71 NPC1 (0.46) KCNH2NPC1RAB9AL3MBTL1TSHR
Hydrochloric Acid SCHEMBL30481157 0.70 NPC1 (0.45) KCNH2NPC1RAB9AL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077324-A1 NOVEL COMPOUNDS AND THEIR USE Debiopharm International SA (CH) 2022-10-26 — — EP claimed
WO-2021123372-A1 NOVEL COMPOUNDS AND THEIR USE DEBIOPHARM INTERNATIONAL S.A. (CH) 2021-06-24 — — WO claimed
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 — — EP claimed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 — — WO claimed
EP-2054422-A1 ACRYLAMIDE DERIVATIVES AS FAB I INHIBITORS Affinium Pharmaceuticals, Inc. (CA) 2009-05-06 — — EP disclosed
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 — — EP disclosed
WO-2008009122-A1 ACRYLAMIDE DERIVATIVES AS FAB I INHIBITORS AFFINIUM PHARMACEUTICALS, INC. (CA) 2008-01-24 — — WO disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 — — WO disclosed
Send feedback